MedHaus Schweiz GmbH – Trademark Portfolio

Entity Type: 16

MedHaus Schweiz GmbH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NOVEL, NORDWAY, and PRO MEDICA.

Bahnhofstrasse 27

CH-6300 Zug

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NOVEL
NOVEL
Registered 2023
NORDWAY
NORDWAY
Registered 2023

Trademark Classifications

MedHaus Schweiz GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does MedHaus Schweiz GmbH have?

MedHaus Schweiz GmbH has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does MedHaus Schweiz GmbH file in?

MedHaus Schweiz GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MedHaus Schweiz GmbH's most well-known trademarks?

MedHaus Schweiz GmbH's registered trademark portfolio includes well-known marks such as NOVEL, NORDWAY, and PRO MEDICA. These are among 3 currently registered trademarks in the portfolio.

What is MedHaus Schweiz GmbH's trademark registration success rate?

MedHaus Schweiz GmbH has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.